LAWRENCE KWONG to Bile Duct Neoplasms
This is a "connection" page, showing publications LAWRENCE KWONG has written about Bile Duct Neoplasms.
Connection Strength
3.125
-
IDH1 Inhibition Reawakens the Immune Response against Cholangiocarcinoma. Cancer Discov. 2022 03 01; 12(3):604-605.
Score: 0.585
-
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma. Hepatology. 2022 02; 75(2):297-308.
Score: 0.575
-
Cholangiocarcinoma Risk Factors Open the Floodgates for Gut Microbes and Immunosuppressive Myeloid Cells. Cancer Discov. 2021 05; 11(5):1014-1015.
Score: 0.552
-
Insights Into the Origin of Intrahepatic Cholangiocarcinoma From Mouse Models. Hepatology. 2020 07; 72(1):305-314.
Score: 0.521
-
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep. 2017 03 14; 18(11):2780-2794.
Score: 0.414
-
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. JCO Precis Oncol. 2024 Mar; 8:e2300544.
Score: 0.168
-
Convergent MAPK pathway alterations mediate acquired?resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma. J Hepatol. 2024 Feb; 80(2):322-334.
Score: 0.165
-
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors. JCO Precis Oncol. 2022 02; 6:e2100197.
Score: 0.145